Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Retatrutide

TRIUMPH-9

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 600

NCT07357415

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Retatrutide Dose Escalation 1n/rn/rn/rn/r
Retatrutide Dose Escalation 2n/rn/rn/rn/r
Retatrutide Dose Escalation 3n/rn/rn/rn/r

Not shown

  • Retatrutide Dose Escalation 1: endpoint not reported
  • Retatrutide Dose Escalation 2: endpoint not reported
  • Retatrutide Dose Escalation 3: endpoint not reported